EYPT
EyePoint, Inc.
NASDAQ · Healthcare · Biotechnology · US
$3.85
−3.51%Next report
Analyst consensus
- Next report date
- Nov 4, 2026
- EPS estimate
- -$0.91
- Revenue estimate
- $231.2K
Latest reported
- Last report date
- Aug 5, 2026
- EPS actual
- -$1.09
- EPS estimate
- -$1.01
- Revenue actual
- $507.0K
- Revenue estimate
- $451.2K
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 4
- EPS misses (12Q)
- 7
- EPS in line (12Q)
- 1
- Avg surprise (4Q)
- -11.9%
- Revenue beats (12Q)
- 8
Analyst ratings
Sell-side consensus
- Consensus
- Buy
- Price target
- $25
- PT range
- $4.00 – $68
- Analysts
- 10
5 Buy5 Hold0 Sell
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 5, 2026 | -$1.01 | -$1.09 | Miss -7.92% | $507.0K |
| May 6, 2026 | -$0.79 | -$0.99 | Miss -25.32% | $696.0K |
| Mar 4, 2026 | -$0.78 | -$0.81 | Miss -3.85% | $620.0K |
| Nov 5, 2025 | -$0.77 | -$0.85 | Miss -10.39% | $966.0K |
| May 7, 2025 | -$0.65 | -$0.65 | In line | $24.5M |
| Mar 5, 2025 | -$0.54 | -$0.64 | Miss -18.52% | $11.6M |
| Nov 7, 2024 | -$0.48 | -$0.54 | Miss -12.50% | $10.5M |
| Mar 7, 2024 | -$0.60 | -$0.33 | Beat 45.00% | $14.0M |
| Nov 1, 2023 | -$0.62 | -$0.33 | Beat 46.77% | $15.2M |
| Aug 2, 2023 | $0.41 | -$0.61 | Miss -248.78% | $9.1M |
| May 3, 2023 | -$0.65 | -$0.56 | Beat 13.85% | $7.7M |
| Mar 2, 2023 | -$0.63 | -$0.61 | Beat 3.17% | $10.5M |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 4, 2026